Stock Market News

1 week AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025 MarketWatch

AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson’s disease on Monday and said it’s on track to seek approval for the drug from the Food and Drug Administration in 2025.

AbbVie (ABBV)

23 hours AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

2 days AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors Zacks

2 days AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors Seeking Alpha

2 days ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

2 days ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

7 days Betting Big On AbbVie: A Prescription For Growth And Dividends Seeking Alpha

1 week AbbVie’s Recently Acquired Parkinson’s Drug Meets Third Study Goal Zacks

1 week The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

1 week Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

1 week AbbVie reports positive results in Parkinson’s trial Investing.com

2 weeks Calls of the Day: Toast, Abbvie, Berkshire Hathaway YouTube

2 weeks AbbVie Inc. (ABBV) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha

2 weeks Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Zacks

2 weeks Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform Yahoo Finance

3 weeks Why Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report? Zacks

3 weeks Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead Seeking Alpha

3 weeks AbbVie Stock Rises After Leerink Partners Upgrades Its Rating Zacks

4 weeks AbbVie: Upgrading To ‘Strong Buy’ After Pullback Seeking Alpha

4 weeks Trade Tracker: Jim Lebenthal buys more Abbvie YouTube

4 weeks AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback Investor's Business Daily

4 weeks AbbVie, Nvidia Lead Friday’s Market Cap Stock Movers Investing.com

4 weeks Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? Zacks

4 weeks Where Will AbbVie Be in 5 Years? Yahoo Finance

4 weeks AbbVie’s Ovarian Cancer Drug Elahere Gets Approval in Europe Zacks

1 month Dividend King AbbVie Just Paid Investors: Here’s How Much They Got 24/7 Wall St.

1 month Pharma Stock Roundup: AZN, BAYRY’s Earnings, ABBV’s Pipeline Setback Zacks

1 month AbbVie Stock Falls 11% in a Month: Should You Buy the Dip? Zacks

1 month Final Trades: Bitcoin, Abbvie and Baker Hughes YouTube

1 month Aldeyra’s FDA Resubmission And AbbVie Option Revitalize Reproxalap’s Prospects Seeking Alpha

1 month AbbVie’s Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio Yahoo Finance

1 month Final Trades: Lyft, Meta, United States Oil Fund & Abbvie YouTube

1 month AbbVie And Pfizer: Q3 Dividend Checkup Post-Earnings Seeking Alpha

1 month Is AbbVie Still A Strong Buy After Fantastic Gains? (Rating Downgrade) Seeking Alpha

1 month AbbVie Stock: Keep Calm And Buy The Dip Seeking Alpha

1 month Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ Investor's Business Daily

1 month AbbVie Tumbles After New Schizophrenia Drug Fails Two Trials Yahoo Finance

1 month RHHBY or ABBV: Which Is the Better Value Stock Right Now? Zacks

1 month Analyst Report: AbbVie Inc Yahoo Finance

1 month Market Digest: THRM, DINO, KLAC, OKE, RJF, SYK, META, ABBV, NCLH Yahoo Finance

2 months Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in Focus Zacks

2 months AbbVie (NYSE:ABBV) Releases Quarterly Earnings Results, Beats Estimates By $0.08 EPS MarketBeat

2 months AbbVie: 3 Positives From The Earnings Report Seeking Alpha

2 months AbbVie Inc. (NYSE:ABBV) Short Interest Up 8.9% in October MarketBeat

2 months AbbVie Trumps Q3 Earnings & Sales Estimates, Raises ’24 EPS View Zacks

2 months AbbVie (NYSE:ABBV) Stock Price Up 3.2% After Dividend Announcement MarketBeat

2 months Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key Metrics Zacks

2 months AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, Rinvoq Investing.com

2 months AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat Investor's Business Daily

2 months Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts? Zacks

2 months AbbVie (NYSE:ABBV) Shares Up 1.1% After Analyst Upgrade MarketBeat

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.